OPKO Health Submits Premarket Approval Application with FDA for a Point-of-Care PSA Test with the Claros® 1 Platform
Go back to OPKO Health Submits Premarket Approval Application with FDA for a Point-of-Care PSA Test with the Claros® 1 Platform| OPKO HEALTH, Inc. (NASDAQ: OPK) | Delayed: 1.46 +0.03 (2.10%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.43 | 52 Week High | $11.85 | |||
| Open | $1.42 | 52 Week Low | $7.12 | |||
| Day High | $1.49 | P/E | N/A | |||
| Day Low | $1.41 | EPS | $-0.30 | |||
| Volume | 2,843,134 | |||||
